PYC Therapeutics Limited (AU:PYC) has released an update. PYC Therapeutics has received Orphan Drug Designation from the US FDA for its ...
Review explores how microRNAs (miRNAs) interact in cancer development, their potential in diagnosis, and innovative ...
Gilead Sciences (GILD) and Merck (MRK) announced new results from a Phase 2 clinical study evaluating the investigational combination of ...